Skip to main content
. 2015 Sep 1;9(9):PC01–PC04. doi: 10.7860/JCDR/2015/15253.6461

[Table/Fig-5]:

Outcomes of various subgroups

Outcome Luminal A Luminal B Triple negative Her 2 enriched p-value
Disease Free Survival 73.18% 70.76% 70.19% 67.16% 0.926
Overall Survival 91.06% 89.23% 88.46% 85.07% 0.598